Evidence map›Paper›PMID 38541986›Full record

ReviewJournal of clinical medicine2024

Inferior Vena Cava Filters: A Clinical Review and Future Perspectives.

Raffaella Benedetti, Simone Marino, Flavio Tangianu, Davide Imberti

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Utilization and Outcomes of Inferior Vena Cava Filter Use.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Raffaella BenedettiHaemostasis and Thrombosis Center, Department of Internal Medicine, Hospital of Piacenza, 29121 Piacenza, Italy.
Simone MarinoDepartment of Internal Medicine, Ospedale di Circolo e Fondazione Macchi, 21100 Varese, Italy.
Flavio TangianuDepartment of Internal Medicine, Ospedale di Circolo e Fondazione Macchi, 21100 Varese, Italy.
Davide ImbertiHaemostasis and Thrombosis Center, Department of Internal Medicine, Hospital of Piacenza, 29121 Piacenza, Italy.
Ospedale di Circolo e Fondazione Macchi · ITOspedaliera di Piacenza · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anticoagulation represents the first line treatment for venous thromboembolism (VTE). However, inferior vena cava (IVC) filter insertion can be considered as a possible therapeutic strategy when anticoagulant therapy is contraindicated, to avoid embolization from the lower limbs to pulmonary circulation. Other possible indications are debated among experts. Both permanent and retrievable caval filters are available in clinical practice. Retrievable filters can be removed when no longer necessary, as their use may be indicated only for a limited amount of time. Moreover, caval filter insertion is not devoid of possible complications, particularly in cases of permanent or long-dwelling filters. A multidisciplinary approach is recommended to review the appropriateness of caval filter use and to define the best timing for retrieval.

Indexed as

caval filterdeep vein thrombosispulmonary embolismvenous thromboembolism

Identifiers

PMID38541986
PMCPMC10971000
OpenAlexW4392950550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.